What Changed FDA's Mind About Ilaris for Gout?

(MedPage Today) -- The FDA quietly approved the interleukin (IL)-1 inhibitor canakinumab (Ilaris) for gout 10 days ago, with no announcement from either the agency or the drug's manufacturer, Novartis -- leaving outsiders to guess at what changed...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Gout | Primary Care